Position in ABBV
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$16,819,617
+$2,773,678 QoQ
Shares Held
66,840
+3.5% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.31%
of 13F equity value
Holder Rank
#687
of 4,153 holders
Holding Since
Sep 2020
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Summit Trail Advisors, LLC holds $121,589,141 across 15 Drug Manufacturers - General names. ABBV ranks #3 (13.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
29,075 | $34,873,430 | |
| 2 | JNJ |
Johnson & Johnson
|
102,279 | $25,975,797 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
66,840 | $16,819,617 | |
| 4 | MRK |
Merck & Co., Inc.
|
84,812 | $10,898,342 | |
| 5 | AMGN |
Amgen Inc
|
16,519 | $5,981,860 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
43,955 | $5,553,274 | |
| 7 | PFE |
Pfizer Inc
|
209,089 | $5,034,863 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
71,425 | $4,115,508 |
All Filings in ABBV
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $16,819,617 | 66,840 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $14,045,939 | 64,582 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $11,072,168 | 48,458 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $11,320,685 | 48,893 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $7,988,713 | 43,038 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $7,546,910 | 36,020 | Shares | Sole | 2025-04-28 | |
| 2024-12-31 | $5,237,885 | 29,476 | Shares | Sole | 2025-01-29 | |
| 2024-09-30 | $4,823,054 | 24,423 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $3,526,108 | 20,558 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $3,211,151 | 17,634 | Shares | Sole | 2024-04-23 | |
| 2023-12-31 | $3,136,902 | 20,242 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $2,880,137 | 19,322 | Shares | Sole | 2023-10-30 | |
| 2023-06-30 | $2,360,604 | 17,521 | Shares | Sole | 2023-07-25 | |
| 2023-03-31 | $1,062,201 | 6,665 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $1,012,486 | 6,265 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $786,873 | 5,863 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $481,535 | 3,144 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $512,429 | 3,161 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $331,188 | 2,446 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $259,211 | 2,403 | Shares | Sole | 2021-11-16 | |
| 2020-09-30 | $313,922 | 3,584 | Shares | Sole | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||